Impact of low-dose quetiapine-use on glycosylated hemoglobin, triglyceride and cholesterol levels.

Mikkel Hojlund Eeva-Liisa Røssell Johansen Kjeld Andersen Christoph U Correll Nina Sahlertz Kristiansen

Published in: Acta psychiatrica Scandinavica (2022)

Low-dose quetiapine was associated with a significant increase in fTG and decreases in HDL-C in all subjects, as well as with significant increases in HbA1c, TC, and LDL-C among those with normal baseline values. The risk of metabolic worsening with quetiapine was dose-dependent, except for fTG.

Keyphrases

low dose
low density lipoprotein
high dose